ETFELA

ETFELA, also known as N-ethyl-N-(2,2,2-trifluoroethyl)lysergamide, is an analogue of lysergic acid diethylamide (LSD) first synthesized by Jason C. Parrish as part of the research team led by David E. Nichols. In studies in vitro, it was found to be slightly more potent than LSD itself.^[1][2]

Other namesN-Ethyl-N-(2,2,2-trifluoroethyl)lysergamide; LA-CH₂CF₃

Drug classSerotonin receptor modulator

CAS Number

• 3024529-99-2 ^Y

PubChem CID

• 163187757

Quick facts Clinical data, Other names ...

ETFELA

Clinical data
Other names	N-Ethyl-N-(2,2,2-trifluoroethyl)lysergamide; LA-CH2CF3
Drug class	Serotonin receptor modulator
Identifiers
IUPAC name (6aR,9R)-N-Ethyl-7-methyl-N-(2,2,2-trifluoroethyl)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
CAS Number	3024529-99-2 Y
PubChem CID	163187757
CompTox Dashboard (EPA)	DTXSID201337080
Chemical and physical data
Formula	C20H22F3N3O
Molar mass	377.411 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC(F)(F)F
InChI InChI=1S/C20H22F3N3O/c1-3-26(11-20(21,22)23)19(27)13-7-15-14-5-4-6-16-18(14)12(9-24-16)8-17(15)25(2)10-13/h4-7,9,13,17,24H,3,8,10-11H2,1-2H3/t13-,17-/m1/s1 Key:VAHPXTJQSWECIC-CXAGYDPISA-N

Close